How Eye Cells Recover from Damage in Inherited Vision Loss
Vulnerable and Resilient Cells in Retinal Degeneration
This project explores how some eye cells might naturally recover from damage that causes inherited vision loss, hoping to find new ways to protect sight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11178673 on NIH RePORTER |
What this research studies
Inherited retinal degeneration causes progressive vision loss and eventual blindness because light-sensing cells in the eye, called photoreceptors, die. While this cell death was once thought to be irreversible, new findings suggest some cells can actually recover from damage. This work aims to understand if photoreceptor cells have a natural ability to "self-repair" or bounce back from damage. Researchers are using special mouse models to identify which cells are vulnerable and which are resilient, with the goal of developing treatments that could boost this natural recovery process.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients, but future clinical applications would target individuals with inherited retinal degeneration.
Not a fit: Patients without inherited retinal degeneration would not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that help preserve vision by encouraging eye cells to repair themselves in people with inherited retinal diseases.
How similar studies have performed: The concept of cells recovering from apoptotic signals, known as "anastasis," has been observed in other biological systems, suggesting a basis for this novel approach in retinal cells.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Chen, Shiming — Washington University
- Study coordinator: Chen, Shiming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.